NexgenRx Inc.
NXG.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 182.73% | 90.51% | 69.00% | -8,256.67% | -109.06% |
| Total Depreciation and Amortization | -5.10% | -4.68% | -7.05% | -10.44% | -9.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -69.49% | -70.48% | -72.63% | -72.84% | 110.63% |
| Change in Net Operating Assets | 25.79% | 175.28% | 71.49% | 138.58% | -171.12% |
| Cash from Operations | 138.37% | 51.01% | 10.83% | 14.01% | -89.95% |
| Capital Expenditure | -125.88% | 64.23% | 78.86% | 81.49% | 134.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.19% | 20.66% | -539.92% | -38.89% | 67.59% |
| Cash from Investing | -482.20% | 46.81% | 33.49% | 53.95% | 105.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -25.13% | 2.51% | 44.90% | 61.94% | 70.43% |
| Issuance of Common Stock | 200.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -66.50% | 5.83% | -58.79% | 4.60% | 45.25% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -44.87% | 27.50% | -10.10% | 21.12% | 56.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -97.58% | 204.79% | 204.63% | 119.90% | -103.39% |
